Glauco Akelinghton Freire VItiello

Dr. Glauco Akelinghton Freire VItiello

Instituto para Pesquisa do Câncer
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

23 January 2018 in Journal of Cancer Research and Clinical Oncology
Verified
Journal Article
Closed access
PDF file
Glauco Akelinghton Freire VItielloGlauco Akelinghton Freire VItiello
Glauco Akelinghton Freire VItiello
RGRoberta Losi Guembarovski
Roberta Losi Guembarovski
BHBruna Karina Banin Hirata
Bruna Karina Banin Hirata
MAMarla Karine Amarante
Marla Karine Amarante
COCarlos Eduardo Coral de Oliveira
Carlos Eduardo Coral de Oliveira
MWMaria Angelica Ehara Watanabe
Maria Angelica Ehara Watanabe

28 April 2017 in Clinical and Experimental Medicine
Verified
Journal Article
Closed access
PDF file
CCClodoaldo Zago Campos
Clodoaldo Zago Campos
RGRoberta Losi Guembarovski
Roberta Losi Guembarovski
COCarlos Eduardo Coral de Oliveira
Carlos Eduardo Coral de Oliveira
BHBruna Karina Banin Hirata
Bruna Karina Banin Hirata
Glauco Akelinghton Freire VItielloGlauco Akelinghton Freire VItiello
Glauco Akelinghton Freire VItiello
TMTânia Longo Mazzuco
Tânia Longo Mazzuco

20 June 2018 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
AGAlda Losi Guembarovski
Alda Losi Guembarovski
RGRoberta Losi Guembarovski
Roberta Losi Guembarovski
BHBruna Karina Banin Hirata
Bruna Karina Banin Hirata
Glauco Akelinghton Freire VItielloGlauco Akelinghton Freire VItiello
Glauco Akelinghton Freire VItiello
KSKaren Mayumi Suzuki
Karen Mayumi Suzuki
EREdna Maria Vissoci Reiche
Edna Maria Vissoci Reiche

1 March 2018 in Cytokine
Verified
Journal Article
Closed access
Glauco Akelinghton Freire VItielloGlauco Akelinghton Freire VItiello
Glauco Akelinghton Freire VItiello
RGRoberta Losi Guembarovski
Roberta Losi Guembarovski
MAMarla Amarante
Marla Amarante
JCJesus Roberto Ceribelli
Jesus Roberto Ceribelli
ECElaine Cristina Baraldi Carmelo
Elaine Cristina Baraldi Carmelo
MWMaria Angelica Ehara Watanabe
Maria Angelica Ehara Watanabe

NPNathália Pereira
Nathália Pereira
Glauco Akelinghton Freire VItielloGlauco Akelinghton Freire VItiello
Glauco Akelinghton Freire VItiello
BBBruna Karina Banin-Hirata
Bruna Karina Banin-Hirata
GFGlaura Scantamburlo Fernandes
Glaura Scantamburlo Fernandes
MSMaria José Sparça Salles
Maria José Sparça Salles
MWMaria Angelica Ehara Watanabe
Maria Angelica Ehara Watanabe
Background: Breast cancer (BC) is a complex disease in which susceptibility and clinical course depend on multiple factors. Evidence suggests that a mouse mammary tumor virus (MMTV)-homolog may be present in human BCs; however, little is known about its clinical implications. Methods: MMTV-like env nucleotide-sequence was searched in tumor and tumor-adjacent tissues from 217 Brazilian BC patients through nested-PCR and confirmed through PCR-sequencing. Blood samples were also tested for patients with MMTV-like env gene-positive tumors. Correlations with clinicopathological parameters were evaluated. Results: MMTV-like env sequence was detected in tumor and tumor-adjacent tissue samples from 41/217 and 30/196 patients, respectively. In blood, MMTV-like was detected in 17/32 patients. In Luminal-B tumors, MMTV-like in tumor tissue was negatively correlated with tumor size and disease stage, whereas in HER2 tumors it anti-correlated with lymph node metastasis (LNM) and disease stage. Considering blood, MMTV-like env gene positivity negatively correlated with age in general BC, while in Luminal-A tumors it positively correlated with Ki67 but negatively correlated with age and LNM. The associations with decreased LNM frequency were independent of other prognostic factors. Conclusion: MMTV-like env positivity is associated with better prognostic parameters in BC subtypes, which might be explainable by its anti-metastatic potential and by putative activation of immune milieu.